Biological Material Analysis TRIZ Cases

Primary human endothelial cells with pH-sensitive dyes measure intracellular fluorescence to predict non-specific antibody clearance accurately.

Asprosin biomarkers identify early-stage pancreatic cancer with high sensitivity, overcoming poor specificity of CA 19-9.

Bovine serum diluent and sodium acetate cleansing solution reduce non-specific binding errors in indirect ELISA assays.

Lectin-bound extracellular vesicles improve pancreatic cancer detection sensitivity and specificity beyond traditional protein tumor markers.

A biomaterial detection sensor uses an erythrocyte membrane conformally covering a metal nanoparticle to selectively react with fibrinogen.

Segmented nano-wells and electrochemical detection resolve the trade-off between high measurement precision and small sample volume requirements.

An absorbent pad captures solid supports from fluid samples to prevent transfer loss, enabling accurate analyte quantification with reduced volumes.

Pan-influenza antibodies replace labor-intensive strain-specific assays to reduce vaccine production delays.

Engineered fully human antibody targets VEGFR2 domain 3 to resolve limited binding affinity and therapeutic efficacy in cancer treatment.

Alpha3 domain peptides induce specific antibodies that block tolerogenic receptors to restore immune function.

Merging V1-V2 and CD4 binding sites into a single molecule overcomes the limited neutralization breadth of conventional monospecific antibodies.

Cyclodextrin-functionalized metal nanoparticles enhance Raman signals for trace analyte detection.

A mechanical agitator mixes liquid samples to accelerate antibody binding, resolving slow passive diffusion limits.

Hydrocortisone mediates HSV-1 infection to induce clear lip lesions, resolving the bottleneck of unclear symptoms in conventional animal models.

Segmented diagnostic sections enable rapid point-of-care detection of thyroid biomarkers, resolving delays in standard laboratory assays.

Phosphorylated myosin-IIA S1943 residues predict metastasis without complex multi-parameter analysis systems.

Segmented capillary tubes with antigen-binding entities resolve measurement precision versus separation reliability contradictions.

Distinct antibody binding sites eliminate cross-reactions with non-gliadin food antigens, ensuring accurate gliadin measurement.

VlsE IR6 and OspC peptides detect Lyme disease antibodies across multiple Borrelia strains, resolving sensitivity gaps in C6 assays.

PKC and PHLPP1 protein ratios predict patient survival, resolving inadequate prognostic reliability in current diagnostic methods.

A diagnostic system measures antibody isotypes to determine Plasmodium vivax infection timing.

Humanized anti-LAG-3 antibodies bind LAG-3 with high affinity, inhibiting immune evasion and enhancing T-cell proliferation in cancer treatment protocols.

Quantifies specific protease enzymes via mass spectrometry to distinguish planktonic and biofilm Candida albicans infections.

Recombinant production of mAb006-11 resolves HBIG batch variation and availability limits while delivering superior cross-genotype neutralizing activity.

Separate biotin-labeled control reagents decouple control line intensity from analyte concentration, resolving measurement precision trade-offs.

Segmented nanosensors with oligopeptide linkages enable sensitive cytokine detection without enzymatic cleavage, resolving specificity limits in airway samples.

A diagnostic method uses primed donor T-cells to detect antigens in patient samples.

Replacing endogenous mouse Protein C genes with human sequences creates viable models that overcome neonatal lethality and plasma incompatibility.

Replacing optical components with electrochemical sensors resolves device complexity while maintaining measurement precision for point-of-care testing.

Modulators disrupt endotoxin-masker complexes to resolve false negative results in pharmaceutical testing.

Lowering tumor temperature to 32-34°C restores mutant p53 DNA binding, enhancing chemotherapy efficacy.

Engineered antigen binding molecules specifically target the murine T cell receptor alpha chain constant region for precise molecular recognition.

A protein biomarker panel detects autism spectrum disorder through biochemical measurement of specific expression levels.

Extracellular vesicles enable frequent longitudinal monitoring of tissue complement deposition, replacing invasive biopsies with liquid analysis.

Block copolymers sequester interfering matrix components to minimize background signals, improving reproducibility in point-of-care tests.

Self-assembled gold nanorod dimers enable rapid, portable detection of wheat gluten without complex instrumentation.

Fluorescent donor and acceptor probes quantify GPCR activation states, resolving measurement precision and diagnostic reliability contradictions.

IL1β-depleting agents treat castration-resistant prostate cancer by inhibiting metastasis of androgen receptor negative cells.

Size exclusion chromatography and acid dissociation detect neutralizing autoantibodies, enabling treatment optimization.

Replacing one antibody with a lectin reduces preparation time while maintaining measurement precision.

Bispecific ligands access signaling plasticity by segmenting binding interfaces, resolving engineering complexity constraints.

Transcriptomic and proteomic data capture thermal stress responses in coral holobionts to identify specific molecular biomarkers.

Orienting linear viruses via streptavidin-biotin interactions increases surface area and antibody density while PEG layers prevent non-specific adsorption.

Porous silicon biosensors detect wound bioanalytes through FRET quenching, replacing slow traditional assays with rapid optical signals.

A human monoclonal antibody binds TIM-3 markers on malignant cells to enable selective therapeutic intervention.

Specific monoclonal antibodies target HCV E2 Epitope II to neutralize genotype 1a infectivity and prevent recurrence in liver transplant patients.

Label-free optical imaging detects mass changes in single T cells and target cells to identify cytotoxic activity without fluorescent markers.

Fetal calf serum and glycerol stabilize antibody-enzyme conjugates, reducing background noise and false positives in ovulation detection.